PANIC-ATTAC: A mouse model for inducible and reversible β-cell ablation

59Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.
Get full text

Abstract

OBJECTIVE-Islet transplantations have been performed clinically, but their practical applications are limited. An extensive effort has been made toward the identification of pancreatic (β-cell stem cells that has yielded many insights to date, yet targeted reconstitution of β-cell mass remains elusive. Here, we present a mouse model for inducible and reversible ablation of pancreatic β-cells named the PANIC-ATTAC (pancreatic islet β-cell apoptosis through targeted activation of caspase 8) mouse. RESEARCH DESIGN AND METHODS-We efficiently induce β-cell death through apoptosis and concomitant hyperglycemia by administration of a chemical dimerizer to the transgenic mice. In contrast to animals administered streptozotocin, the diabetes phenotype and β-cell loss are fully reversible in the PANIC- ATTAC mice, and we find significant β-cell recovery with normalization of glucose levels after 2 months. RESULTS-The rate of recovery can be enhanced by various pharmacological interventions with agents acting on the gluca- gon-like peptide 1 axis and agonists of peroxisome proliferator- activated receptor-γ. During recovery, we find an increased population of GLUT2 +/insulin- cells in the islets of PANIC- ATTAC mice, which may represent a novel pool of potential β-cell precursors. CONCLUSIONS-The PANIC-ATTAC mouse may be used as an animal model of inducible and reversible β-cell ablation and therefore has applications in many areas of diabetes research that include identification of β-cell precursors, evaluation of glucotoxicity effects in diabetes, and examination of pharmaco- logical interventions. © 2008 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Wang, Z. V., Mu, J., Schraw, T. D., Gautron, L., Elmquist, J. K., Zhang, B. B., … Scherer, P. E. (2008). PANIC-ATTAC: A mouse model for inducible and reversible β-cell ablation. Diabetes, 57(8), 2137–2148. https://doi.org/10.2337/db07-1631

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free